Istradefylline API Market Projected to Witness Robust Growth, Reaching USD 2.5 Billion by 2032 https://dataintelo.com/report/global-istradefylline-api-market The global Istradefylline API Market is set to experience significant growth, with projections indicating a rise to USD 2.5 billion by 2032, growing at a CAGR of 13.4% from 2023 to 2032. The market is driven by the increasing demand for Parkinson’s disease treatments, the rise in clinical trials involving Istradefylline, and the overall growing focus on improving neurological health. Istradefylline, a selective A2A receptor antagonist, has shown promising results in treating Parkinson’s disease, making it a focal point for pharmaceutical companies and researchers. As the number of Parkinson’s cases continues to rise globally, the demand for innovative treatments like Istradefylline is expected to soar. For in-depth analysis, visit the Istradefylline API Market.